Related Experiment Video
Updated: Jan 26, 2026

A Porcine Corneal Endothelial Organ Culture Model Using Split Corneal Buttons
Published on: October 6, 2019
Corneal thickness and endothelial changes in long-term hydroxychloroquine use
Tevfik Oğurel1, Murat Atabey Özer2, Yaprak Akbulut1
1a Department of Ophthalmology, Medical Faculty, Kırıkkale University , Kırıkkale , Turkey.
Insights
Long-term hydroxychloroquine (HCQ) use in rheumatologic patients is associated with significant corneal changes. Specifically, patients showed decreased corneal endothelial cell density and increased central corneal thickness compared to controls.
Area of Science:
- Ophthalmology
- Rheumatology
- Pharmacology
Background:
- Hydroxychloroquine (HCQ) is widely prescribed for rheumatologic conditions.
- Long-term use may lead to ocular toxicity, including corneal changes.
- Monitoring corneal health is crucial for patients on HCQ therapy.
Purpose of the Study:
- To investigate the association between long-term HCQ use (≥3 years) and specific corneal parameters.
- To compare corneal endothelial cell density (ECD), central corneal thickness (CCT), cell size variation (CV), and hexagonal cell percentage (HEX%) between HCQ users and controls.
Main Methods:
- A comparative study involving 62 patients on long-term HCQ for rheumatologic diseases and 62 healthy controls.
- Corneal assessments included CCT, ECD, CV, and HEX%.
- Data collected during HCQ retinal toxicity screening.
Main Results:
- Patients on long-term HCQ exhibited significantly lower mean ECD (2742 cells/mm²) compared to controls (2875 cells/mm²; p=0.01).
- Mean CCT was significantly higher in the HCQ group (567.05 µm) versus controls (540.15 µm; p<0.001).
- No significant differences were found in CV or HEX% between the groups (p>0.05).
Conclusions:
- Long-term HCQ use is linked to reduced corneal endothelial cell density and increased central corneal thickness.
- Corneal endothelial cell morphology (CV and HEX%) does not appear significantly altered by long-term HCQ.
- These findings highlight potential structural corneal changes associated with HCQ therapy.
Abstract:
Objective: To determine possible associations between long-term HCQ use and corneal changes in patients who used HCQ for at least 3 years. Materials and methods: The study included 62 healthy controls and 62 consecutive patients who used HCQ for the treatment of rheumatologic disease and were referred to the ophthalmology department between August 2018 and November 2018 for HCQ retinal toxicity screening. Central corneal thickness (CCT), corneal endothelial cell density (ECD), the coefficient of variation (CV) of cell size, and the percentage of hexagonal cells (HEX%) were measured to evaluate changes in the cornea. Results: The mean age of the patient group and control group was 50.10 ± 10.91 and 50.53 ± 10.67 years, respectively. The mean ECD was 2742 ± 347 (cells/mm2) in the patient group and 2875 ± 188 cells/mm2 in the control group. There was a significant difference between groups (p = 0.01). The mean CCT was 567.05 ± 32.35 µm in the patient group and 540.15 ± 38.50 µm in the control group. CCT was significantly higher in the patient group compared with control group (p < 0.001). There was no significant difference between groups in terms of mean CV and HEX values (p > 0.05). Conclusions: Patients using long-term HCQ demonstrated lower ECD and higher CCT than the control group. However, the CV of cell sizes and the HEX % values were not significantly different from the controls.
Related Concept Videos
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Design Example: Deciding Thickness of Lubricating Fluid in a Shaft
To calculate the required thickness of the lubricant layer, the tangential velocity at the shaft's surface must first be determined. This velocity is calculated by converting the rotational speed to angular velocity...
Directional Terms
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Long-term Potentiation

